An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

HELIOS-B is a global, randomized, double-blind, placebo-controlled clinical trial that evaluated the efficacy and safety of AMVUTTRA (R) in adult patients with wtATTR or hATTR amyloidosis with ...

Researchers at the Institute of Nano Science and Technology (INST), Mohali, have identified a new pathway involving ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

A new study shows that components found in aged blood can speed up the buildup of amyloid proteins and alter behavior in an ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...